CN1925741A - 动物基因分型方法 - Google Patents
动物基因分型方法 Download PDFInfo
- Publication number
- CN1925741A CN1925741A CN03817455.3A CN03817455A CN1925741A CN 1925741 A CN1925741 A CN 1925741A CN 03817455 A CN03817455 A CN 03817455A CN 1925741 A CN1925741 A CN 1925741A
- Authority
- CN
- China
- Prior art keywords
- milk
- casein
- beta
- dna
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241001465754 Metazoa Species 0.000 title claims description 64
- 238000003205 genotyping method Methods 0.000 title description 13
- 108010076119 Caseins Proteins 0.000 claims abstract description 109
- 102000011632 Caseins Human genes 0.000 claims abstract description 93
- 235000013336 milk Nutrition 0.000 claims abstract description 93
- 210000004080 milk Anatomy 0.000 claims abstract description 93
- 239000008267 milk Substances 0.000 claims abstract description 93
- 235000021247 β-casein Nutrition 0.000 claims abstract description 68
- 238000000034 method Methods 0.000 claims abstract description 57
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 57
- 241000283690 Bos taurus Species 0.000 claims abstract description 39
- 239000003550 marker Substances 0.000 claims abstract description 19
- 230000006399 behavior Effects 0.000 claims description 17
- 239000005018 casein Substances 0.000 claims description 11
- 235000018102 proteins Nutrition 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 210000000582 semen Anatomy 0.000 claims description 9
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- 235000013305 food Nutrition 0.000 claims description 6
- 230000000392 somatic effect Effects 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 5
- 229930195729 fatty acid Natural products 0.000 claims description 5
- 239000000194 fatty acid Substances 0.000 claims description 5
- 150000004665 fatty acids Chemical class 0.000 claims description 5
- 235000021246 κ-casein Nutrition 0.000 claims description 5
- 210000001161 mammalian embryo Anatomy 0.000 claims description 4
- 102000010445 Lactoferrin Human genes 0.000 claims description 3
- 108010063045 Lactoferrin Proteins 0.000 claims description 3
- 239000005862 Whey Substances 0.000 claims description 3
- 102000007544 Whey Proteins Human genes 0.000 claims description 3
- 108010046377 Whey Proteins Proteins 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 244000309464 bull Species 0.000 claims description 3
- 235000019197 fats Nutrition 0.000 claims description 3
- 210000004209 hair Anatomy 0.000 claims description 3
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 3
- 230000006651 lactation Effects 0.000 claims description 3
- 229940078795 lactoferrin Drugs 0.000 claims description 3
- 235000021242 lactoferrin Nutrition 0.000 claims description 3
- 102000006395 Globulins Human genes 0.000 claims description 2
- 108010044091 Globulins Proteins 0.000 claims description 2
- 230000002759 chromosomal effect Effects 0.000 claims 1
- 238000012360 testing method Methods 0.000 abstract description 5
- 108020004414 DNA Proteins 0.000 description 62
- 102000054766 genetic haplotypes Human genes 0.000 description 21
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 11
- 235000021240 caseins Nutrition 0.000 description 11
- 238000003752 polymerase chain reaction Methods 0.000 description 11
- 239000000203 mixture Substances 0.000 description 6
- 239000013612 plasmid Substances 0.000 description 6
- 108700024394 Exon Proteins 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- 101150075200 S-2 gene Proteins 0.000 description 4
- 108091008146 restriction endonucleases Proteins 0.000 description 4
- 101100038000 Nicotiana alata S-2 gene Proteins 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 108700028369 Alleles Proteins 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical group N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 235000013365 dairy product Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 244000144992 flock Species 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000008774 maternal effect Effects 0.000 description 2
- 235000021243 milk fat Nutrition 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 241000283725 Bos Species 0.000 description 1
- 229930183912 Cytidylic acid Natural products 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 108060002716 Exonuclease Proteins 0.000 description 1
- 108010033040 Histones Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229940021722 caseins Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- IERHLVCPSMICTF-XVFCMESISA-N cytidine 5'-monophosphate Chemical group O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(O)=O)O1 IERHLVCPSMICTF-XVFCMESISA-N 0.000 description 1
- IERHLVCPSMICTF-UHFFFAOYSA-N cytidine monophosphate Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(COP(O)(O)=O)O1 IERHLVCPSMICTF-UHFFFAOYSA-N 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-N diphosphoric acid Chemical compound OP(O)(=O)OP(O)(O)=O XPPKVPWEQAFLFU-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 102000013165 exonuclease Human genes 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 230000009027 insemination Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940005657 pyrophosphoric acid Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 235000021249 α-casein Nutrition 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/101—Bovine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/02—Animal zootechnically ameliorated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/124—Animal traits, i.e. production traits, including athletic performance or the like
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
动物ID | 单体型 | ||||||||||
ac69 | ac70 | ac55 | ac57 | A1或2 | ac58 | ac59 | ac60 | ac61 | ac63 | ac64 | |
87203a87203b500150025003500450055006501950225023502550275029503250345035503650375038504050445045504850495050505350545055505650575061506250645065506650695070 | CCTTCCTCCCCTCCCCCTCTTTTCCTCCCCCCCCTCCC | AACCAACAAAACAAAAACACCCCAACAAAAAAAACAAA | CTCCCTCCTCTCCCTTCTCCCCTTCCTCCTTCCCCCCT | CTTTTTTTTTCTTCTTTTCTCTTTTTTTTTTTTTTTTT | A1A2A1A2A2A2A2A1A1A1A2A2A1A1A2A2A1A2A1A2A2A2A2A1A1A1A2A1A1A2A2A1A1A2A1A1A1A2 | CCTTTTTTCTCCTTCTTTTCTTTTCTTTTTTTTTTCCC | GAGGAGGAGAGAGGAAAAGAGGGGGGGGGAAGGAGGGG | TCTCTCCTTTCCTTCCTTTCCCCTTTCTTCCCTTTTTC | GAAAAAAGGGAAGGAAGAGAAAAGGGAGGAAGGAGGGA | TGTGTGGTTTGGTTGGTTTGGGGTTTGTTGGTTTTTTG | TCCCCCCTTTCCTTCCTCTCCCCCTTCTTCCTTCTTTC |
β-酪蛋白基因外的标记单体型 | β-酪蛋白核苷酸200(A1/A2) | |||
AC61 | AC59 | AC63 | nC(A2) | nA(A1) |
AAAAGG | AAGGAG | GTGTGT | 739 | 1315 |
Claims (25)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NZ51916602 | 2002-05-24 | ||
NZ519166 | 2002-05-24 | ||
PCT/NZ2003/000102 WO2003100074A2 (en) | 2002-05-24 | 2003-05-23 | Animal genotyping method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1925741A true CN1925741A (zh) | 2007-03-07 |
CN1925741B CN1925741B (zh) | 2010-11-10 |
Family
ID=29580122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN03817455.3A Expired - Lifetime CN1925741B (zh) | 2002-05-24 | 2003-05-23 | 动物基因分型方法 |
Country Status (10)
Country | Link |
---|---|
US (1) | US7629119B2 (zh) |
EP (1) | EP1573033A4 (zh) |
JP (1) | JP4549848B2 (zh) |
KR (1) | KR101001821B1 (zh) |
CN (1) | CN1925741B (zh) |
AU (1) | AU2003234372B2 (zh) |
CA (1) | CA2487322C (zh) |
HK (1) | HK1101054A1 (zh) |
NZ (1) | NZ537363A (zh) |
WO (1) | WO2003100074A2 (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105018581A (zh) * | 2014-04-29 | 2015-11-04 | 上海桑尼生物科技有限公司 | 一种基于测序法检测β-酪蛋白基因型的方法 |
CN105018582A (zh) * | 2014-04-29 | 2015-11-04 | 上海桑尼生物科技有限公司 | 一种基于酶切法检测β-酪蛋白基因型的方法 |
CN105010233A (zh) * | 2015-08-11 | 2015-11-04 | 吉林康大食品有限公司 | 一种应用snp辅助选择育种技术培育高繁殖性能种兔的方法 |
CN105200120A (zh) * | 2014-06-18 | 2015-12-30 | 上海派森诺生物科技有限公司 | 一种基于荧光定量PCR技术检测β-酪蛋白基因型的方法 |
CN105219839A (zh) * | 2014-06-18 | 2016-01-06 | 上海派森诺生物科技有限公司 | 一种基于酶切法检测β-酪蛋白基因型的方法 |
CN105861671A (zh) * | 2015-12-10 | 2016-08-17 | 中国农业大学 | 检测奶牛β-酪蛋白基因SNP的引物组合物及其用途 |
CN107058582A (zh) * | 2017-06-06 | 2017-08-18 | 北京奶牛中心 | 基于KASP检测β‑酪蛋白基因型的方法 |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA200506094B (en) | 2002-12-31 | 2006-11-29 | Mmi Genomics Inc | Compositions, methods and systems for inferring bovine traits |
WO2010119088A2 (en) * | 2009-04-15 | 2010-10-21 | Bodo Melnik | Milk and milk-based products modified to exhibit a reduced insulinemic index and/or reduced mitogenic activity |
CN107287292B (zh) * | 2017-06-07 | 2019-11-26 | 山东省农业科学院奶牛研究中心 | 同时检测奶牛β-酪蛋白不同变体型的一组专用引物及其试剂盒 |
CN108841971B (zh) * | 2018-07-13 | 2021-11-23 | 西北农林科技大学 | 一种检测黄牛sh3pxd2b基因插入/缺失标记的方法 |
CN111887301A (zh) * | 2019-05-06 | 2020-11-06 | 临清乳泰牧业有限公司 | 一种乳蛋白牛奶及其制备方法 |
CN110863034B (zh) * | 2019-12-05 | 2022-05-31 | 北京康普森生物技术有限公司 | 快速提取牛血液DNA进行β-酪蛋白基因型检测的方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK8892D0 (da) * | 1992-01-23 | 1992-01-23 | Symbicom Ab | Humant proteingen |
WO1996014577A1 (en) * | 1994-11-04 | 1996-05-17 | The National Child Health Research Foundation | Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected |
US6570060B2 (en) * | 1995-05-16 | 2003-05-27 | Mclachlan Corran Norman Stuart | Milk lacking β-casein A1 |
ATE297125T1 (de) * | 1995-05-16 | 2005-06-15 | A2 Corp Ltd | Nahrungsmittel und herstellungsverfahren |
-
2003
- 2003-05-23 KR KR1020047019045A patent/KR101001821B1/ko active IP Right Grant
- 2003-05-23 CN CN03817455.3A patent/CN1925741B/zh not_active Expired - Lifetime
- 2003-05-23 JP JP2004507514A patent/JP4549848B2/ja not_active Expired - Lifetime
- 2003-05-23 NZ NZ537363A patent/NZ537363A/en not_active IP Right Cessation
- 2003-05-23 WO PCT/NZ2003/000102 patent/WO2003100074A2/en active Application Filing
- 2003-05-23 US US10/515,940 patent/US7629119B2/en active Active
- 2003-05-23 CA CA2487322A patent/CA2487322C/en not_active Expired - Lifetime
- 2003-05-23 AU AU2003234372A patent/AU2003234372B2/en not_active Expired
- 2003-05-23 EP EP03728181A patent/EP1573033A4/en not_active Withdrawn
-
2007
- 2007-08-13 HK HK07108740.9A patent/HK1101054A1/xx not_active IP Right Cessation
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105018581A (zh) * | 2014-04-29 | 2015-11-04 | 上海桑尼生物科技有限公司 | 一种基于测序法检测β-酪蛋白基因型的方法 |
CN105018582A (zh) * | 2014-04-29 | 2015-11-04 | 上海桑尼生物科技有限公司 | 一种基于酶切法检测β-酪蛋白基因型的方法 |
CN105200120A (zh) * | 2014-06-18 | 2015-12-30 | 上海派森诺生物科技有限公司 | 一种基于荧光定量PCR技术检测β-酪蛋白基因型的方法 |
CN105219839A (zh) * | 2014-06-18 | 2016-01-06 | 上海派森诺生物科技有限公司 | 一种基于酶切法检测β-酪蛋白基因型的方法 |
CN105010233A (zh) * | 2015-08-11 | 2015-11-04 | 吉林康大食品有限公司 | 一种应用snp辅助选择育种技术培育高繁殖性能种兔的方法 |
CN105861671A (zh) * | 2015-12-10 | 2016-08-17 | 中国农业大学 | 检测奶牛β-酪蛋白基因SNP的引物组合物及其用途 |
CN107058582A (zh) * | 2017-06-06 | 2017-08-18 | 北京奶牛中心 | 基于KASP检测β‑酪蛋白基因型的方法 |
Also Published As
Publication number | Publication date |
---|---|
KR101001821B1 (ko) | 2010-12-15 |
AU2003234372A1 (en) | 2003-12-12 |
US20070264408A1 (en) | 2007-11-15 |
KR20050049430A (ko) | 2005-05-25 |
WO2003100074A3 (en) | 2007-11-22 |
WO2003100074A8 (en) | 2008-01-17 |
HK1101054A1 (en) | 2007-10-05 |
EP1573033A4 (en) | 2009-03-04 |
AU2003234372B2 (en) | 2009-09-17 |
CA2487322C (en) | 2013-07-16 |
US7629119B2 (en) | 2009-12-08 |
CA2487322A1 (en) | 2003-12-04 |
CN1925741B (zh) | 2010-11-10 |
JP2005528898A (ja) | 2005-09-29 |
WO2003100074A2 (en) | 2003-12-04 |
JP4549848B2 (ja) | 2010-09-22 |
EP1573033A2 (en) | 2005-09-14 |
NZ537363A (en) | 2010-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1896284A (zh) | 一种鉴别等位基因类型的方法 | |
CN1925741A (zh) | 动物基因分型方法 | |
CN1483081A (zh) | 新的prkag3等位基因及其作为生殖和肉质性状的遗传标记的应用 | |
CN1263559A (zh) | 分析动物产品的方法 | |
CN1193102C (zh) | 黑皮质素-4受体基因及其作为动物脂肪含量、体重增加和/或饲料消耗的遗传标记的用途 | |
CN1886521A (zh) | Cmv抗性相关分子标志及其用途 | |
CN1633500A (zh) | 用于持家基因mRNA检测的核酸扩增用引物和使用该引物的检查方法 | |
CN1668635A (zh) | 新钙蛋白酶抑制蛋白(cast)等位基因 | |
CN1717477A (zh) | 恢复细胞的甲基化状态 | |
CN1402787A (zh) | AMPKγ链的变体、其DNA编码序列及其用途 | |
CN1712543A (zh) | Leber’s遗传性视神经病的定量检测方法 | |
CN101048504A (zh) | 对干扰素治疗肾细胞癌反应的鉴定标记 | |
CN1671841A (zh) | 基因多态性分型方法 | |
CN1503847A (zh) | 用于鉴定牛脊椎畸形综合征携带者的遗传试验 | |
CN1957091A (zh) | K-ras寡核苷酸微型阵列及用其检测K-ras突变的方法 | |
CN1708589A (zh) | Cns中crh应答基因 | |
CN1693481A (zh) | 定制的微阵列构建体及其在靶分子检测中的应用 | |
CN1496402A (zh) | 表达基因鉴定用cDNA标记物的制备方法和基因表达分析方法 | |
CN1958605A (zh) | Spg3a基因突变、其编码产物及其应用 | |
CN1606622A (zh) | 通过全面检测和定量食物中毒细菌的热稳定直接溶血素相关的基因 ( t d h ) 相关溶血素基因)对产溶血素细菌进行检测和定量的方法 | |
CN1769445A (zh) | 生理节律调控基因簇、dna芯片以及使用该dna芯片的方法 | |
CN100335654C (zh) | 检测微转移的方法 | |
CN1229493C (zh) | 携带人原癌基因的哺乳动物癌细胞和转基因哺乳动物以及利用上述原癌基因的癌症诊断试剂盒 | |
CN1505640A (zh) | T细胞受体Vβ-Dβ-Jβ序列及其检测方法 | |
CN101033487A (zh) | 检测与原发性高血压相关的KLK1基因rs5517多态的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1101054 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1101054 Country of ref document: HK |
|
C56 | Change in the name or address of the patentee |
Owner name: A2 MILK COMPANY LTD. Free format text: FORMER NAME: A2 CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: Oakland, New Zealand Patentee after: THE A2 MILK CO.,LTD. Address before: Oakland, New Zealand Patentee before: A2 Corp.,Ltd. |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20101110 |